Navigation Links
Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions
Date:10/16/2007

our therapeutic focus areas in cardiovascular and metabolic diseases."

"We are pleased to be working with Isis, a leader in the discovery and development of RNA-based therapeutics," stated Pratik Shah, Ph.D., partner at Thomas, McNerney & Partners, which structured and led the licensing and financing transactions for Altair. "Asthma continues to be an area of unmet medical need and we believe ISIS 369645 has the potential to provide significant benefit to patients. There have been a number of recent clinical successes and validating corporate partnerships that make this space exciting."

"A key component of our business strategy is to exploit the broad applicability of our antisense technology platform and our intellectual property position to add to our pipeline of promising antisense drugs that target a broad range of diseases," said B. Lynne Parshall, Executive Vice President and CFO of Isis. "To best accomplish this, we have created and partnered with numerous emerging biotech companies focused on exploiting antisense technology toward new biological areas or particular diseases, providing them with access to our technology, intellectual property or licenses to certain of our drugs. Altair is now joining the ranks of these partners, which include Alnylam Pharmaceuticals, OncoGenex Technologies, Regulus Therapeutics, ATL, iCo Therapeutics and others. We believe that each of these partners is a highly dedicated, innovative company through which we are aggressively furthering the development of antisense drugs, expanding the breadth of our product pipeline, and creating value, while staying focused on our internal drug discovery and development activities and core technology expansion."

About Altair Therapeutics

Altair was founded by Thomas, McNerney & Partners and is building a dedicated team, combining antisense drug discovery expertise with respiratory drug development expertise, to focus solely on the development and commercialization of
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Jellyfish partners for sales tracking technology
4. GE Healthcare partners with UNC on breast cancer imaging research
5. Manufacturing partnership will move into biotech and biomedical spaces
6. Fergus joins Baird Venture Partners, Caden Bio
7. Avolte Venture Partners reaches capital goal
8. NimbleGen partners with UK biotech firm
9. Big pharma seeks Wisconsin biotech partnerships
10. Thompson in partnership to build ethanol plant
11. Johnson Controls partners on car satellite linkup
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Scientists, researchers, and technologists will converge ... Damage 2014 symposium. Marking its 46th year, the ... run 14-17 September. The event is sponsored by ... , The premier conference for basic and applied issues ... materials will engage researchers and engineers from numerous industries ...
(Date:8/28/2014)... MA (PRWEB) August 28, 2014 ... wholesale construction materials, selected SoundConnect to ... their cloud based audio and web conferencing platform ... to support PrimeSource’s employees’ needs. SoundConnect delivers ... , PrimeSource Building Products will be utilizing ...
(Date:8/27/2014)... August 27, 2014 Varian Medical Systems ... its current Salt Lake City manufacturing facility and allow ... Utah to ultimately create 1,000 new full time jobs ... , “Utah is home to hardworking people with immense ... credited with Varian’s success in the manufacturing of our ...
(Date:8/27/2014)... California (PRWEB) August 27, 2014 ... (LLNL), through Lawrence Livermore National Security LLC ... to develop and deliver a state-of-the-art laser system ... facility (ELI Beamlines), under construction in the Czech ... performance, the laser system, called the " High ...
Breaking Biology Technology:Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3PrimeSource Chooses SoundConnect as Collaboration Provider 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3LLNL Synchs up with ELI Beamlines on Timing System 2LLNL Synchs up with ELI Beamlines on Timing System 3
... in Greek , Italian , Japanese and ... scientists from the University of Bristol has developed a new approach ... calculations that cannot be done by today,s computers. Scientists ... that could be used to perform complex calculations and simulations using ...
... SAN FRANCISCO, Sept. 16 In response to recent ... a biobusiness park in Minnesota, Burrill & Company would ... "We have been in active discussions ... an interest in the project," said G. Steven Burrill, ...
... DIEGO, Sept. 16 Prometheus Laboratories Inc., a ... a business unit of Cedars-Sinai Medical Center, today ... and license agreement.  The collaboration will focus on ... responses to anti-TNF therapies such as Cimzia®, Humira® ...
Cached Biology Technology:Optical chip enables new approach to quantum computing 2Optical chip enables new approach to quantum computing 3Burrill & Company Responds to Recent Press Coverage About Biopark Investment at Elk Run 2Prometheus and Tarrot Laboratories Collaborate to Identify Markers Associated With Response to Anti-TNF Therapies in Crohn's Disease 2
(Date:8/28/2014)... A unique method for delivering compounds that ... HIV and AIDS may be possible, thanks ... Agricultural Sciences., A semi-soft vaginal suppository made ... loaded with the antiviral drug Tenofovir provides ... against the spread of sexually transmitted infections ...
(Date:8/28/2014)... of complex systems. Their infrastructure equipment requires ancillary ... transport to supply fuel, and ICT systems for ... chain is interconnected with a wider network and ... UK-based scientists has studied various aspects of inter-network ... published in EPJ B by Gaihua Fu from ...
(Date:8/28/2014)... 28, 2014 Dyslexia, the most commonly diagnosed ... neurological reading disability that occurs when the regions ... function normally. , The use of non-invasive functional ... is disrupted in dyslexia. However, most prior work ... brain regions, leaving a gap in our understanding ...
Breaking Biology News(10 mins):Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Inter-dependent networks stress test 2Dyslexic readers have disrupted network connections in the brain 2
... genetically modified (GM) food are threatening public acceptance of ... are also hampering Europe,s response to the global challenge ... researchers claim. Drawing upon a decade of evidence, ... say that Europe,s regulation of GM crops has become ...
... of Louisville bioengineering researchers will use a $3.33 million ... commercialize promising academic innovations into medical solutions to benefit ... the ultimate goal of focusing on outcomes to save, ... million contribution, UofL,s program will have a $1 million ...
... The Translational Genomics Research Institute (TGen) is part of ... grant from Susan G. Komen for the Cure to ... this cancer that disproportionately affects African-Americans. The Komen ... and scientists called Promise Grants, multi-million dollar, multi-year, collaborative ...
Cached Biology News:TGen breast cancer research benefits from $3.5 million Komen award 2TGen breast cancer research benefits from $3.5 million Komen award 3